000 03231cam a2200385 a 4500
005 20250930130318.0
008 100122s2003 sz a b i001 0 eng
020 _a9241546018
039 9 _a201002051051
_bruzini
_y01-22-2010
_zratnab
040 _aUKM
060 _aW74.1
_b.M235 2003 9
090 _aW74.1.M235 2003 9 who
245 0 0 _aMaking choices in health :
_bWHO guide to cost-effectiveness analysis /
_cedited by T. Tan-Torres Edejer ... [et al.]
246 3 0 _aWHO guide to cost-effectiveness analysis
260 _aGeneva :
_bWorld Health Organization,
_c2003
300 _axiii, 312, [8] p. :
_bill. ;
_c24 cm.
504 _aIncludes bibliographical references and index
505 0 _aPart One: METHODS FOR GENERALIZED COST-EFFECTIVENESS -- Ch. 1. What is generalized cost-effectiveness analysis? -- Ch. 2. Undertaking a study using GCEA -- Ch. 3. Estimating costs -- Ch. 4. Estimating health effects -- Ch. 5. Discounting -- Ch. 6. Uncertainty in cost-effectiveness analysis -- Ch. 7. Policy uses of generalized CEA -- Ch. 8. Reporting CEA results -- Ch. 9. Summary of recommendations -- Annex A. WHO-CHOICE activities on generalized cost-effectiveness analysis -- Annex B. Draft list of intervention clusters for evaluation by WHO-CHOICE -- Annex C. An illustration of the types of costs included in a selection of intervention activities at central levels -- Annex D. Interpreting international dollars -- Annex E. DALYs to measure burden of dollars -- Annex F. Measuring intervention benefit at the population level -- Annex G. Epidemiological subregions as applied in WHO generalized CEA -- Part Two: BACKGROUND PAPERS AND APPLICATIONS -- Ch. 1. Development of WHO guidelines on generalized cost-effectiveness analysis -- Ch. 2. PopMod: a longitudinal population model with two interacting disease states -- Ch. 3. Programme costs in the economic evaluation of health interventions -- Ch. 4. Econometric estimation of country-specific hospital costs -- Ch. 5. Stochastic league tables: communicating cost-effectiveness results to decision-makers -- Ch. 6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables -- Ch. 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk -- Ch. 8. Generalized cost-effectiveness analysis: an aid to decision making in health -- Ch. 9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources
650 2 _aCost-Benefit Analysis
_xmethods
650 2 _aHealth Planning
_xmethods
650 2 _aHealth Care Rationing
_xeconomics
650 2 _aHealth Priorities
_xeconomics
650 2 _aPolicy Making
650 2 _aDecision Support Techniques
650 2 _aModels, Econometric
650 2 _aHealth Care Costs
700 1 _aEdejer, Tessa Tan-Torres
710 2 _aWorld Health Organization
_948759
907 _a.b14646523
_b2019-11-12
_c2019-11-12
942 _c3
_n0
_kW74.1.M235 2003 9 who
914 _avtls003425153
991 _aPerpustakaan Dr. Abdul Latiff, KKL
998 _ad
_b2010-09-01
_cm
_da
_feng
_gsz
_y0
_z.b14646523
999 _c456372
_d456372